U.S. drugmaker Pfizer could work its connections within President Donald Trump's administration to try to thwart Novo Nordisk's surprise rival bid to acquire U.S. obesity biotech firm Metsera, ...
The takeover battle between Novo Nordisk and Pfizer to land weight-loss drug maker Metsera is a sign of "an accelerating M&A ...
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback